These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
523 related items for PubMed ID: 23981805
1. Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents. Hashiguchi Y, Hamada A, Shinohara T, Tsuchiya K, Jono H, Saito H. Biochem Biophys Res Commun; 2013 Sep 20; 439(2):221-7. PubMed ID: 23981805 [Abstract] [Full Text] [Related]
2. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines. Fujimoto H, Higuchi M, Watanabe H, Koh Y, Ghosh AK, Mitsuya H, Tanoue N, Hamada A, Saito H. Biol Pharm Bull; 2009 Sep 20; 32(9):1588-93. PubMed ID: 19721237 [Abstract] [Full Text] [Related]
3. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir. Janneh O, Anwar T, Jungbauer C, Kopp S, Khoo SH, Back DJ, Chiba P. Antivir Ther; 2009 Sep 20; 14(7):965-74. PubMed ID: 19918100 [Abstract] [Full Text] [Related]
4. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates. Mandíková J, Volková M, Pávek P, Česnek M, Janeba Z, Kubíček V, Trejtnar F. Toxicology; 2013 Sep 15; 311(3):135-46. PubMed ID: 23856525 [Abstract] [Full Text] [Related]
5. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters. Hoque MT, Kis O, De Rosa MF, Bendayan R. Antimicrob Agents Chemother; 2015 May 15; 59(5):2572-82. PubMed ID: 25691630 [Abstract] [Full Text] [Related]
6. Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes. Janneh O, Jones E, Chandler B, Owen A, Khoo SH. J Antimicrob Chemother; 2007 Nov 15; 60(5):987-93. PubMed ID: 17890284 [Abstract] [Full Text] [Related]
7. pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: potential role in antiretroviral drug oral bioavailability and drug-drug interactions. Kis O, Zastre JA, Ramaswamy M, Bendayan R. J Pharmacol Exp Ther; 2010 Sep 01; 334(3):1009-22. PubMed ID: 20507927 [Abstract] [Full Text] [Related]
8. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. Drug Metab Dispos; 1999 Aug 01; 27(8):866-71. PubMed ID: 10421612 [Abstract] [Full Text] [Related]
9. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells. Hira A, Watanabe H, Maeda Y, Yokoo K, Sanematsu E, Fujii J, Sasaki J, Hamada A, Saito H. Biochem Pharmacol; 2008 Feb 15; 75(4):973-80. PubMed ID: 18054347 [Abstract] [Full Text] [Related]
10. Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors. Tempestilli M, Gentilotti E, Tommasi C, Nicastri E, Martini F, De Nardo P, Narciso P, Pucillo LP. Int Immunopharmacol; 2013 Aug 15; 16(4):492-7. PubMed ID: 23707228 [Abstract] [Full Text] [Related]
14. IPEC-J2 MDR1, a Novel High-Resistance Cell Line with Functional Expression of Human P-glycoprotein (ABCB1) for Drug Screening Studies. Saaby L, Helms HC, Brodin B. Mol Pharm; 2016 Feb 01; 13(2):640-52. PubMed ID: 26651362 [Abstract] [Full Text] [Related]
18. Inhibitory effect of human immunodeficiency virus protease inhibitors on multidrug resistance transporter P-glycoproteins. Shiraki N, Hamada A, Yasuda K, Fujii J, Arimori K, Nakano M. Biol Pharm Bull; 2000 Dec 01; 23(12):1528-31. PubMed ID: 11145192 [Abstract] [Full Text] [Related]
19. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Honda Y, Ushigome F, Koyabu N, Morimoto S, Shoyama Y, Uchiumi T, Kuwano M, Ohtani H, Sawada Y. Br J Pharmacol; 2004 Dec 01; 143(7):856-64. PubMed ID: 15504753 [Abstract] [Full Text] [Related]